In situ studies of orbital tissue from patients with thyroid-associated ophthalmopathy

References

• Wall J R, Salvi M, Bernard N F, Boucher A, Haegert D. Thyroidassociated ophthalmopathy-a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12: 150–153
   PubMedGoogle Scholar
• Weetman A P. Thyroid-associated eye disease: Pathophysiology. Lancet 1991; 338: 25–28
   PubMed Web of Science ®Google Scholar
• Gorman C A. Pathogenesis of Graves' ophthalmopathy. Thyroid 1994; 4: 379–383
   PubMedGoogle Scholar
• Hiromatsu Y, Tanaka K, Ishisaka N, et al. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metabol 1995; 80: 685–691
   PubMedGoogle Scholar
• Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease, expressed in the thyroid and extraocular muscle. J Clin Endocrinol Metabol 1991; 72: 1375–1381
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Higashide T, Nakase Y, Inoue T, Inoue Y, Shiga H. Role of rectus muscle enlargement in clinical profile of dysthyroid ophthalmopathy. Jpn J Ophthalmol 1991; 35: 175–181
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Kojima K, Ishisaka N, et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosup-pressive therapy. Thyroid 1992; 2: 299–305
   PubMedGoogle Scholar
• Rieber E P. T-cell section report. Leukocyte Typing IV: White Cell Differentiation Antigens, W Knapp, B Dorken, W R Gilks, et al. Oxford University Press, New York 1989; 229–249
   Google Scholar
• Gross B, Misrahi M, Sar S, Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun 1991; 177: 679–687
   PubMedGoogle Scholar
• Tanaka K, Hiromatsu Y, Sato M, Inoue Y, Nonaka K. Localization of heat shock protein in orbital tissue from patients with Graves' ophthalmopathy using in situ hybridization. Life Sci 1994; 54: 355–359
   PubMedGoogle Scholar
• Chomczynski P, Sacchi N. Singlestep method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Tokunaga K, Nakamura Y, Sakata K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47: 5616–5619
   PubMed Web of Science ®Google Scholar
• Fox R I, Kang H-I, Ando D, et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152: 5532–5539
   PubMed Web of Science ®Google Scholar
• Huang X, Yuan J, Goddark A, et al. Interferon expression in the pancreas of patients with type I diabetes. Diabetes 1995; 44: 558–664
   Google Scholar
• Watson P F, Pickerill A P, Davies R, Weetman A P. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metabol 1994; 79: 355–360
   PubMed Web of Science ®Google Scholar
• Weetman A P, Cohen S, Gatter K C, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227
   PubMed Web of Science ®Google Scholar
• Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988; 29: 175–184
   PubMed Web of Science ®Google Scholar
• Kroll A J, Kuwabara T. Dysthyroid ocular myopathy: anatomy, histology and electron microscopy. Arch Ophthalmol 1966; 76: 244–257
   PubMedGoogle Scholar
• Heufelder A E, Bahn R S. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23: 10–17
   PubMed Web of Science ®Google Scholar
• McLachlan S M, Prummel M F, Rapoport B. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metabol 1994; 78: 1070–1074
   PubMed Web of Science ®Google Scholar
• Botazzo G F, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii: 1115–1119
   Google Scholar
• Gimmi C D, Freeman G J, Gribben J G, Gray G, Nadler L M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586–6590
   PubMed Web of Science ®Google Scholar
• Asuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76–78
   PubMedGoogle Scholar
• Weetman A P. Antigen presentation in the pathogenesis of autoimmune endocrine disease. J Autoimmunity 1995; 8: 305–312
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Fukazawa H, How J, Wall J R. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibro-blasts in Graves' ophthalmopathy-roles of class II MHC antigen expression and γ-interferon action on effector and target cells. Clin Exp Immunol 1987; 70: 597–603
   Web of Science ®Google Scholar
• Heufelder A E, Wenzel B E, Bahn R S. Cell surface localization of a 72 kilodalton heat shock protein in retro-ocular fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metabol 1992; 74: 732–736
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Goellner J R, Wenzel B E, Bahn R S. Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease. J Clin Endocrinol Metabol 1992; 74: 724–731
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Bahn R S. Modulation of intercellular adhesion molecule-1 (ICAM-1) by cytokines and Graves' IgGs in cultured Graves' retroocular fibroblasts. Ear J Clin Invest 1992; 22: 529–537
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Bahn R S, Boergen K P, Scriba P C. Nachweis, Lokalisation und Modulation der CD44/Hyaluronsäure-Rezeptor Expression bei Patienten mit endocriner Orbitopathie. Med Klinik 1993; 88: 181–185
   Google Scholar
• Heufelder A E, Bahn R S. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin Exp Immunol 1993; 92: 296–302
   PubMed Web of Science ®Google Scholar
• Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall J R. Demonstration of a circulating autoantibody against soluble eye muscle antigen in Graves' ophthalmopathy. Lancet 1982; ii: 1353–1356
   Google Scholar
• Kendall-Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J 1984; 288: 1183–1186
   PubMed Web of Science ®Google Scholar
• Mengistu M, Laryea E A, Miller A, Wall J R. Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence. Clin Exp Immunol 1986; 65: 19–27
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J Clin Endocrinol Metabol 1986; 67: 565–570
   Google Scholar
• Salvi M, Miller A, Wall J R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroidassociated ophthalmopathy. FEBS Lett 1988; 232: 135–139
   PubMed Web of Science ®Google Scholar
• Ahmann A, Baker J R, Weetman A P, Wartofsky L, Nutman T B, Burman K D. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy; identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metabol 1987; 64: 454–460
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Sato M, Tanaka K, et al. Significance of anti-eye muscle antibody in patients with thyroidassociated ophthalmopathy by quantitative western blot. Autoimmunity 1992; 14: 9–16
   PubMedGoogle Scholar
• Kendler D L, Rootman J, Huber G K, Davies T F. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic disease. Clin Endocrinol (Oxf) 1991; 35: 539–547
   PubMed Web of Science ®Google Scholar
• Wall J R, Scalise D, Hayes M, et al. Native gel electrophoresis of the 64 kDa protein shows that it is eye muscle specific and an important target for autoantibodies in patients with thyroid-associated ophthalmopathy. Thyroid 1994; 4(Suppl 1)S-92
   Google Scholar
• Kiljanski J, Nebes V, Wall J R. The ocular cell is a target of the immune system in endocrine ophthalmopathy. Int Arch Allergy Immunol 1995; 106: 204–212
   PubMed Web of Science ®Google Scholar
• Teng C S, Smith B R, Anderson J, Hall R. Comparison of thyrotropin receptors in membranes prepared from fat and thyroid tissue. Biochem Biophys Res Commun 1975; 66: 836–841
   PubMedGoogle Scholar
• Perros P, Kendall-Taylor P. Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroidassociated ophthalmopathy. J Endocrinol Invest 1994; 17: 163–170
   PubMedGoogle Scholar
• Pekonen F, Weintraub B D. Thyrotropin binding to cultured lymphocytes and thyroid cells. Endocrinology 1978; 103: 1668–1677
   PubMedGoogle Scholar
• Roselli-Rehfuss L, Robbins L S, Cone R D. Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 1992; 130: 1857–1861
   PubMed Web of Science ®Google Scholar
• Paschke R, Ellsei R, Vassart G, Ludgate M. Lack of evidence supporting the presence of mRNA for thyrotropin receptor in extraocular muscle. J Endocrinol Invest 1993; 16: 329–332
   PubMedGoogle Scholar
• Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento E V, Fenzi G. Expression of thyrotropinreceptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet. 1993; 342: 337–338
   PubMed Web of Science ®Google Scholar
• Endo T, Ohno M, Kotani S, Gunji K, Onaya T. Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun 1993; 190: 774–779
   PubMedGoogle Scholar
• Heufelder A E, Dutton C M, Sarkar G, Donovan K A, Bahn R S. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid. 1993; 3: 297–300
   PubMed Web of Science ®Google Scholar
• Mengistu M, Lukses Y G, Nagy E V, et al. TSH receptor gene expression in retroocular fibroblasts. J Endocrinol Invest 1994; 17: 437–441
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Tanaka K, Koga M, et al. Significance of thyrotropin receptor mRNA expression in orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Endocrinol Invest 1994; 17(Suppl 1 to 6)44
   Google Scholar
• Francis T, Burch H B, Cai W-Y, et al. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991; 1: 223–228
   PubMedGoogle Scholar
• Wall J R, Strakosch C R, Fang S L, Ingbar S H, Braverman L H. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol 1979; 10: 79–91
   PubMed Web of Science ®Google Scholar
• Benker G, Kotulla P, Kendall-Taylor P, Emrich D, Reinwein D. TSH binding-inhibiting antibodies in hyperthyroidism: relationship to clinical signs and hormone levels. Clin Endocrinol 1989; 30: 19–28
   PubMedGoogle Scholar
• Chang T C, Huang K H, Chang T J, Lin S L. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol 1990; 32: 551–555
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen U, Kemp A, Bech K, Madsen S N, Date J. Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in endocrine exophthalmos. Acta Endocrinol 1981; 96: 192–198
   PubMedGoogle Scholar
• Nishikawa M, Yoshimura M, Toyoda N, et al. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroidstimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol 1993; 129: 213–219
   PubMedGoogle Scholar
• Miyake I, Koga M, Nagasawa N, et al. Clinical significance of antithyrotropin receptor antibodies in thyroid-associated ophthalmopathy. Thyroid 1995; 5(Suppl 1)S185
   PubMedGoogle Scholar